Key Market Indicator:
Stock market news: In short news style a la Twitter/X. Everything that is relevant - at a glance. The entry page for the informed investor. Compact, worth knowing and always up to date. Directly from the IR departments of the companies.
CH1110760852
Fri, 02.12.2022
PolyPeptide
Media Release – ad hoc announcement pursuant to Art. 53 LR
PolyPeptide provides market update
Baar, 2 December 2022 – PolyPeptide Group AG (SIX: PPGN), a focused global CDMO for peptide- and oligonucleotide-based active pharmaceutical ingredients, today provided a market update.
Audio webcast scheduled for today at 09.30 am CET.
Several op [ … ]
Fri, 02.12.2022
PolyPeptide
Media Release – ad hoc announcement pursuant to Art. 53 LR
PolyPeptide provides market update
Baar, 2 December 2022 – PolyPeptide Group AG (SIX: PPGN), a focused global CDMO for peptide- and oligonucleotide-based active pharmaceutical ingredients, today provided a market update.
Audio webcast scheduled for today at 09.30 am CET.
Several op [ … ]
Fri, 19.08.2022
PolyPeptide Group
Media Release – ad hoc announcement pursuant to Art. 53 LR
PolyPeptide with encouraging progress within custom projects pipeline – however with lower profitability in the first half of 2022
Baar, 19 August 2022 – PolyPeptide Group AG (SIX: PPGN), a focused global CDMO for peptide- and oligo-nucleotide-based active phar [ … ]
Fri, 19.08.2022
PolyPeptide Group
Media Release – ad hoc announcement pursuant to Art. 53 LR
PolyPeptide with encouraging progress within custom projects pipeline – however with lower profitability in the first half of 2022
Baar, 19 August 2022 – PolyPeptide Group AG (SIX: PPGN), a focused global CDMO for peptide- and oligo-nucleotide-based active phar [ … ]
Tue, 12.07.2022
PolyPeptide Group
Media Release – ad hoc announcement pursuant to Art. 53 LR
PolyPeptide provides market update
Baar, 12 July 2022 – PolyPeptide Group AG (PolyPeptide), a global leader in peptide and oligonucleotide development and manufacturing, today provides a market update. While investing to implement its growth strategy [ … ]
Tue, 12.07.2022
PolyPeptide Group
Media Release – ad hoc announcement pursuant to Art. 53 LR
PolyPeptide provides market update
Baar, 12 July 2022 – PolyPeptide Group AG (PolyPeptide), a global leader in peptide and oligonucleotide development and manufacturing, today provides a market update. While investing to implement its growth strategy [ … ]
Mon, 09.05.2022
PolyPeptide Group
PolyPeptide Group
/ Key word(s): Personnel
PolyPeptide Group: Monika Casanova joining PolyPeptide as CHRO and member of the PMC
09.05.2022 / 07:00
Monika Casanova joining PolyPeptide as CHRO and member of the PMC
Baar, 9 May 2022 – PolyPeptide Group AG (PolyPeptide), a global leader in peptide development and manufacturing, tod [ … ]
Tue, 26.04.2022
PolyPeptide Group
PolyPeptide Group
/ Key word(s): AGMEGM
PolyPeptide Group announces results of the annual General Meeting 2022
26.04.2022 / 18:00
PolyPeptide announces results of the annual General Meeting 2022
Zug, 26 April 2022 - PolyPeptide Group AG (PolyPeptide), a global leader in peptide development and manufacturing, today announced tha [ … ]
Fri, 01.04.2022
PolyPeptide Group
PolyPeptide Group
/ Key word(s): AGMEGM
PolyPeptide publishes invitation to the annual General Meeting 2022
01.04.2022 / 07:00
PolyPeptide publishes invitation to the annual General Meeting 2022
Zug, 1 April 2022 - PolyPeptide Group AG (PolyPeptide), a global leader in peptide custom development and manufacturing, published tod [ … ]
Tue, 15.03.2022
PolyPeptide Group
Media Release - ad hoc announcement pursuant to Art. 53 LR
PolyPeptide achieves strong profitable growth in 2021
Zug, 15 March 2022 - PolyPeptide Group AG (SIX: PPGN), a global leader in peptide custom development and manufacturing, today announced its results for the financial year 2021:
- Revenue growth of 26.5% year-over-year to EUR 282.1 mil [ … ]